June 14, 2021
2 mins read

Covaxin trials on children set to begin

Delhi AIIMS has decided to start the trial drive after the recruitment and clinical trial for single-dose Covaxin for 12-18 age group is over….reports Asian Lite News

The All India Institute of Medical Sciences (AIIMS) is learnt to have started screening of children aged 6-12 years for the clinical trials of India’s first indigenously developed Covid-19 vaccine, Bharat Biotech’s Covaxin.

Sources said that the recruitment and clinical trials of the children aged 6-12 years will start from Tuesday. The trial on children aged 6-12 has already started at AIIMS Patna.

Participants would be given the vaccine after their screening report comes. The trial would ensure if the Bharat Biotech jab is suitable for children.

Delhi AIIMS has decided to start the trial drive after the recruitment and clinical trial for single-dose Covaxin for 12-18 age group is over.

After the recruitment of 6-12 year-old children, AIIMS Delhi will be conducting trials for the age group 2-6 years of children. The trials are taking place at 525 centres.

Kolkata: Health workers give the 1st dose of vaccine to the Government workers during increasing numbers of COVID 19 cases in Kolkata 24 May, 2021. (Photo: Kuntal Chakrabarty/ IANS
ALSO READ: Delhi gears up to tackle 3rd Covid wave

The screening of children for the trial of single-dose Covaxin among those aged between 2 and 18 years started at the AIIMS in New Delhi on June 7 after India’s drug regulator had granted permission for conducting the Phase 2 and 3 clinical trials of Covaxin in the age group 2 to 18 years on May 12.

AIIMS Patna, Mysore Medical College and Research Institute in Karnataka have also been selected to conduct clinical trials on children.

Covaxin is being used on adults in India’s ongoing Covid-19 vaccination drive since January 16 this year. The government last week cautioned that even though Covid-19 has not taken a serious shape among children till now, its impact can increase among them if there is a change in virus behaviour or epidemiology dynamics, and said preparations are being strengthened to deal with any such situation.

A national expert group has been formed to review Covid-19 infections in children and approach the pandemic in a renewed way to strengthen the nation’s preparedness, NITI Aayog Member (Health) V.K. Paul had said at a press conference.

“The group has examined signs which were not available four-five months before.”

ALSO READ: Delhi Metro resumes operations

Previous Story

‘Sunak’s in-laws face £5.5m demand in Amazon India tax dispute’

Next Story

Adani rules out reports on NSDL freezing accounts

Latest from -Top News

UAE rolls out red carpet for Indian start-ups

MoU signed with IIT Bombay’s SINE as CEPA Start-up Series aims to accelerate market access for Indian ventures In a bid to bolster cross-border entrepreneurship and innovation, the UAE-India CEPA Council (UICC),

Fuel switch mystery in Air India horror crash

Cockpit voice recordings, fuel switch anomalies and a possible overlooked advisory emerge in early findings The preliminary investigation into the crash of Air India flight AI171, which went down shortly after take-off

‘Kill and Dump’ Haunts Balochistan Again

The latest killings have reignited accusations of extrajudicial executions and the use of counterterrorism laws to cover up custodial deaths in Balochistan….reports Asian Lite News Concerns have deepened across Balochistan following the

‘ASEAN Expands, But Keeps Its Soul’

Malaysian Foreign Minister Mohamad Hasan urged ASEAN to uphold its unity and strategic resolve amid intensifying geopolitical tensions and mounting external pressures…reports Asian Lite News Consensus and inclusivity will remain the cornerstones
Go toTop

Don't Miss

Singapore shuts door to Indian visitors

This move takes effect from 11.59 p.m. on Friday, and

China transformed into a full-fledged Surveillance State during Covid

Information flowing through China’s digital networks is closely monitored and